Assistant professor
More information
Work
- Deborah Jael Herrera, Lindy Huber, Allegra Ferrari, Guido Van Hal, Esther Toes-Zoutendijk, Alex Vorsters, Liesbet Van Bos & Wessel van de Veerdonk (2026) - Barriers to and facilitators of cancer prevention services for transgender and gender-diverse people: A systematic review - Preventive Medicine, 206 - doi: 10.1016/j.ypmed.2026.108544 - [link]
- B. Sheridan, L. Rabeneck & E. Toes-Zoutendijk (2026) - Elements of screening and early diagnosis of lower GI neoplastic lesions: an overview - Best Practice and Research: Clinical Gastroenterology, 80 - doi: 10.1016/j.bpg.2025.102052 - [link]
- Mangesh A. Thorat, Marc Arbyn, David Baldwin, Xavier Castells, Solveig Hofvind, Urska Ivanus, Carlo Senore, Esther Toes-Zoutendijk, Carlijn van der Aalst, Carlos Canelo-Aybar, Fiorella Karina Fernández-Sáenz, Ariadna Feliu, Hajo Zeeb, Andre L. Carvalho, Erica D'Souza, David Ritchie, Carolina Espina, Iris Lansdorp-Vogelaar & Andrea DeCensi (2026) - European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer - Molecular Oncology, 20 (1), 117-133 - doi: 10.1002/1878-0261.70158 - [link]
- Esther Toes-Zoutendijk, Marc Arbyn, Anssi Auvinen, David Baldwin, Xavier Castells, Andrea DeCensi, Solveig Hofvind, Urska Ivanus, Carlo Senore, Mangesh Thorat, Carlijn van der Aalst, Ana Carolina Pereira Nunes Pinto, Javier Bracchiglione, Ariadna Feliu, Hajo Zeeb, Erica D'Souza, David Ritchie, Carolina Espina, Andre L. Carvalho & Iris Lansdorp-Vogelaar (2026) - European Code Against Cancer, 5th edition – organised cancer screening programmes - Molecular Oncology, 20 (1), 134-153 - doi: 10.1002/1878-0261.70197 - [link]
- Brenda J. van Stigt, Elyse E.C. Rijnders, Lucie de Jonge, Iris Lansdorp-Vogelaar, Esther Toes-Zoutendijk, Hilliene J. van de Schootbrugge-Vandermeer, Manon C.W. Spaander, Anneke J. van Vuuren, Evelien Dekker, Folkert J. van Kemenade, Iris D. Nagtegaal & Monique E. van Leerdam (2026) - Risk stratification in fecal immunochemical test-based colorectal cancer screening: Public acceptance and experiences with tailored invitation intervals - Preventive Medicine Reports, 61 - doi: 10.1016/j.pmedr.2025.103310 - [link]
- H. J. van de Schootbrugge-Vandermeer, L. de Jonge, M. E. van Leerdam, A. J. van Vuuren, E. Dekker, M. C.W. Spaander, I. D. Nagtegaal, F. J. van Kemenade, I. Lansdorp-Vogelaar & E. Toes-Zoutendijk (2025) - Risk of colorectal cancer and participation in fecal immunochemical test-based screening - Public Health, 248 - doi: 10.1016/j.puhe.2025.105938 - [link]
- Lindy Huber, Tom Bootsma, Carola van Iersel, Sophie Rier, Ida Korfage, Inge M.C.M. de Kok, Franklin Maidman & Esther Toes-Zoutendijk (2025) - Exploring preferences in breast and cervical cancer screening fortransgender individuals: Focus groups with healthcare professionals andtransgender individuals - International Journal of Transgender Health - doi: 10.1080/26895269.2025.2569726 - [link]
- Lucie de Jonge, Esther Toes-Zoutendijk, Rosita van den Puttelaar, Fanny E.R. Vuik, Manon C.W. Spaander & Iris Lansdorp-Vogelaar (2025) - Cost-effectiveness of colon capsule endoscopy in colorectal cancer screening: a modeling study - Endoscopy, 57 (10), 1095-1105 - doi: 10.1055/a-2658-0960 - [link]
- Danica M.N. van den Berg, Lucie de Jonge & Esther Toes-Zoutendijk (2025) - Reply - Gastroenterology, 169 (2), 387-388 - doi: 10.1053/j.gastro.2025.04.019 - [link]
- Maria Alexandra Katsara, Danica van den Berg, Manon C.W. Spaander, Adriana J. van Vuuren, Evelien Dekker, Folkert J. van Kemenade, Iris D. Nagtegaal, Monique E. van Leerdam, Iris Lansdorp-Vogelaar & Esther Toes-Zoutendijk (2025) - The impact of extended invitation intervals on stage distribution of screen-detected and interval cancer within the Dutch colorectal cancer screening program - International Journal of Cancer, 157 (2), 298-304 - doi: 10.1002/ijc.35371 - [link]
Econometrics and OR in Health Care
- Year
- 2025
- Course Code
- FEB23024
Inform Internship & Minor (econometrics)
- Year
- 2025
- Course Code
- FEB62011
